arrow
M

María Monteagudo

spanish national cancer research centre (cnio)
H指数:12
被引数:559

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Molecular profiling unveils genetic complexity and identifies potential new driver mechanisms in head and neck paragangliomas

分子图谱分析揭示了头颈部副神经节瘤的遗传复杂性,并识别了潜在的新的驱动机制。

2025-06-040
OAAI
MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma
2024-12-012
OAAI
Efficacy and safety of regorafenib for the treatment of metastatic colorectal cancer in routine clinical practice: results from a Spanish hospital
2024-11-120
OAAI
REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial

REGISTRI: KIT/PDGFRA野生型转移性GIST的一线Regorafenib: 西班牙 (GEIS),意大利 (ISG) 和法国肉瘤组 (FSG) II期临床试验

2023-08-099
OAAI
Deubiquitinase USP9X loss sensitizes renal cancer cells to mTOR inhibition

去泛素酶USP9X缺失使肾癌细胞对mTOR抑制敏感

2023-06-016
PRE
DLST mutations in pheochromocytoma and paraganglioma cause proteome hyposuccinylation and metabolic remodeling
2023-05-043
OAAI
Comprehensive molecular analysis of immortalization hallmarks in thyroid cancer reveals new prognostic markers
2022-08-1813
OA
Analysis of Telomere Maintenance Related Genes Reveals NOP10 as a New Metastatic-Risk Marker in Pheochromocytoma/Paraganglioma

端粒维持相关基因的分析揭示NOP10是嗜铬细胞瘤/副神经节瘤的新转移风险标志物

CANCERS
IF4.4
2021-09-2315
OAAI
Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome
2020-12-0136
PREAI
CD133 Expression in Medullary Thyroid Cancer Cells Identifies Patients with Poor Prognosis
2020-08-138
OAAI
Sino-European Differences in the Genetic Landscape and Clinical Presentation of Pheochromocytoma and Paraganglioma
2020-08-0530
OAAI